Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Squamous Cell Carcinoma
and you are
over 18
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose is the description of anti-tumor immune responses in general and according to clinical stage and disease free survival (DFS: survival without recurrence (local or distant)) in patients with Head & Neck Squamous Cell Carcinoma Secondary purposes are: - Study of relationship between anti-tumor immune response and qualitative (yes/no) and quantitative (number) presence of circulating tumor cells (CTCs); - Study of relationship between qualitative (yes/no) and quantitative (number) presence of CTCs and clinical stage as well as DFS - Study of relationship between anti-tumor immune response and clinical stage as well as DFS.

Provided treatments

  • Other: Blood sample
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02881918. The sponsor of the trial is Central Hospital, Nancy, France and it is looking for 154 volunteers for the current phase.
Official trial title:
Anti-tumor Specific Immune Response in Head and Neck Cancers